RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 56-66
  • FDA issues new requirements to improve defibrillator safety

    FDA issues new requirements to improve defibrillator safety
    The Food and Drug Administration is requiring makers of heart-zapping defibrillators to submit more data on the emergency care devices after years of recalls and manufacturing problems. Regulators say companies must now submit new testing data on...
  • Drugs expensive under plans sold on health exchange, survey finds

    Drugs expensive under plans sold on health exchange, survey finds
    The Affordable Care Act is not so affordable for many Marylanders, according to a new survey. The landmark law that was supposed to make insurance available to hundreds of thousands of people without coverage is costing Marylanders so much more in...
  • Hogan's budget includes some cuts, some status quo for economic development programs

    Hogan's budget includes some cuts, some status quo for economic development programs
    Advocates for programs spending state dollars on stem cell research or investment in technology companies were nervous about what Gov. Larry Hogan's budget would hold for them, given warnings of "strong medicine" to cure fiscal woes. But after Hogan's...
  • AbbVie's new hepatitis C treatment gets approval in EU

    AbbVie's new hepatitis C treatment gets approval in EU
    Drugmaker AbbVie Inc. said Monday that its new, all-pill hepatitis C combo treatment has been approved for patients in the 28 European Union member countries. The company said the European Commission granted marketing authorization for the combination...
  • Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016

    Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016
    A Northbrook company said it has won fast-track status for approval of a drug that could become the first in the United States to treat Duchenne muscular dystrophy, a fatal muscle disease found most often in boys. Privately held Marathon Pharmaceuticals...
  • Company denies rat poison in pills linked to India sterilization deaths

    Company denies rat poison in pills linked to India sterilization deaths
    The company at the center of a probe into why more than a dozen women died after being sterilized in India has denied that the antibiotic tablets it manufactured were contaminated with a chemical compound commonly found in rat poison. Preliminary tests...
  • Mann steps down as CEO of inhaled insulin maker MannKind Corp.

    Mann steps down as CEO of inhaled insulin maker MannKind Corp.
    Alfred Mann, the billionaire entrepreneur and inventor behind several successful medical device companies, is stepping down as chief executive of MannKind Corp., a Valencia maker of inhaled insulin. Mann, 89, the founder and chief financial backer of...
  • Shire to buy specialty drugmaker NPS Pharma for $5.2 billion

    Irish drugmaker Shire PLC said Sunday it will pay $5.2 billion to acquire NPS Pharmaceuticals, which specializes in drugs for rare conditions. The acquisition will expand Shire's portfolio of specialty drugs, medications for niche diseases and...
  • Walgreens Boots Alliance unveils new logo

    Walgreens Boots Alliance unveils new logo
    Walgreens Boots Alliance unveiled a new logo Friday, a sphere meant to look like a globe that is a corporate departure from the red W that has been a fixture at its U.S. drugstores for years. The logo for the Walgreens stores is not changing, the...
  • AbbVie will rely on arthritis staple, new HCV drug in 2015

    AbbVie will rely on arthritis staple, new HCV drug in 2015
    North Chicago-based AbbVie issued a strong outlook for 2015 on Thursday after the markets closed. The biopharmaceutical company that was spun off from Abbott Laboratories expects earnings per share between $3.99 and $4.19 in 2015. The company said...
  • Express Scripts, CVS Health Dropping Coverage For Many Brand-Name Drugs: Why?

    Express Scripts, which handles prescription-drug benefits for millions of people nationwide, is dropping coverage for 66 brand-name drugs in January in an effort to keep costs down. Rival CVS Health is dropping 95 drugs from its own list of covered drugs....